OBJECTIVE: Efficacy of percutaneous endoscopic gastrostomy (PEG) on unplanned treatment interruption and nutritional status was examined in @entity1 undergoing chemoradiotherapy ( @entity8982 ) for advanced @entity135 . METHODS: We retrospectively reviewed hospital charts of 44 @entity1 with advanced @entity135 who were treated with @entity8982 . RESULTS: @entity8982 -induced @entity33 of grade 3 or worse and inadequate oral intake of less than one third of their usual intake developed in 33 @entity1 who were recommended PEG placement, but not in 11 @entity1 . Thirteen @entity1 accepted PEG placement and then completed @entity8982 (compliant group). However, among 20 @entity1 who refused both PEG and nasogastoric tube (NGT) placements (non-compliant group), 10 required unplanned interruptions of @entity8982 at a radiation dose around 30-40 Gy (UI- @entity8982 group) while 10 others could complete @entity8982 without interruption ( @entity8982 . Total serum protein levels were significantly decreased after @entity8982 in all @entity1 . DISCUSSION: It is suggested that therapeutic PEG placement is useful for preventing unplanned interruption of @entity8982 in @entity1 with advanced @entity135 . After severe @entity33 and inadequate oral intake have developed during @entity8982 , PEG placement should be considered before the radiation therapy dose of 30 Gy. J. Med. Invest. 62: 173-176, August, 2015.

Efficacy of percutaneous endoscopic gastrostomy on unplanned treatment interruption and nutritional status in @entity1 undergoing chemoradiotherapy for advanced XXXX .

@entity1 :: ('9606', 'Species') :: ['patients'] @entity135 :: ('MESH:D006258', 'Disease') :: ['head and neck cancer'] @entity33 :: ('MESH:D052016', 'Disease') :: ['mucositis'] @entity8982 :: ('799', 'Gene') :: ['CRT', 'C-CRT group) CRT']
@entity135 :: (MESH:D006258,Disease) :: ['head and neck cancer']
